Epidemiology of burn-related infections in the largest burn unit in Saudi Arabia

References

1. ↵
   1. Mathers C,
   2. Fat DM,
   3. Boerma JT

   (2008) The global burden of disease:2004 update (World Health Organization, Geneva (SW)).
2. ↵
   1. Othman N,
   2. Kendrick D

   (2010) Epidemiology of burn injuries in the East Mediterranean Region:a systematic review. BMC Public Health 10:83.

   OpenUrlCrossRefPubMed
3. ↵
   1. Smolle C,
   2. Cambiaso-Daniel J,
   3. Forbes AA,
   4. Wurzer P,
   5. Hundeshagen G,
   6. Branski LK,
   7. et al.

   (2017) Recent trends in burn epidemiology worldwide:A systematic review. Burns 43:249–257.

   OpenUrl
4. ↵
   1. Brusselaers N,
   2. Monstrey S,
   3. Vogelaers D,
   4. Hoste E,
   5. Blot S

   (2010) Severe burn injury in Europe:a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care 14:pR188.

   OpenUrl
5. ↵
   1. Yali G,
   2. Jing C,
   3. Chunjiang L,
   4. Cheng Z,
   5. Xiaoqiang L,
   6. Yizhi P

   (2014) Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns 40:402–407.

   OpenUrlCrossRefPubMed
6. ↵
   1. Azzopardi EA,
   2. Azzopardi E,
   3. Camilleri L,
   4. Villapalos J,
   5. Boyce DE,
   6. Dziewulski P,
   7. et al.

   (2014) Gram negative wound infection in hospitalised adult burn patients-systematic review and metanalysis. PLoS One 9:e95042.

   OpenUrlCrossRefPubMed
7. ↵
   1. Bahemia IA,
   2. Muganza A,
   3. Moore R,
   4. Sahid F,
   5. Menezes CN

   (2015) Microbiology and antibiotic resistance in severe burns patients:A 5 year review in an adult burns unit. Burns 41:1536–1542.

   OpenUrlCrossRef
8. ↵
   1. Al-Aali KY

   (2016) Microbial profile of burn wound infections in burn patients, Taif, Saudi Arabia. Arch Clin Microbiol 7:2.

   OpenUrl
9. ↵
   1. van Langeveld I,
   2. Gagnon RC,
   3. Conrad PF,
   4. Gamelli RL,
   5. Martin B,
   6. Choudhry MA,
   7. et al.

   (2017) Multiple-Drug Resistance in Burn Patients:A Retrospective Study on the Impact of Antibiotic Resistance on Survival and Length of Stay. J Burn Care Res 38:99–105.

   OpenUrl
10. ↵
    1. Sen S,
    2. Palmieri T,
    3. Greenhalgh D

    (2014) Review of burn research for the year 2013. J Burn Care Res 35:362–368.

    OpenUrl
11. ↵
    1. Ministry of Health. Al Noor Specialist Hospital

    (2017) Plastic Surgery, [cited 2020], Available from: http://www.nsh.med.sa/Pages/Plastic-surgery.aspx.
12. ↵
    1. Bowler PG,
    2. Duerden BI,
    3. Armstrong DG

    (2001) Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14:244–269.

    OpenUrlAbstract/FREE Full Text
13. ↵
    1. Davies JW

    The problems of burns in India. Burns 1990;Suppl 1:S1–S24.
14. ↵
    1. Hemeda M,
    2. Maher A,
    3. Mabrouk A

    (2003) Epidemiology of burns admitted to Ain Shams University burns unit, Cairo, Egypt. Burns 29:353–358.

    OpenUrlPubMedWeb of Science
15. ↵
    1. World Health Organization

    Burns, [cited 2016 September], Available from: https://www.who.int/news-room/fact-sheets/detail/burns.
16. ↵
    1. Fekih Hassen A,
    2. Ben Khalifa S,
    3. Daiki M

    (2014) Epidemiological and bacteriological profiles in children with burns. Burns 40:1040–1045.

    OpenUrl
17. ↵
    1. Heggers JP,
    2. McCoy L,
    3. Reisner B,
    4. Smith M,
    5. Edgar P,
    6. Ramirez RJ

    (1998) Alternate antimicrobial therapy for vancomycin-resistant enterococci burn wound infections. J Burn Care Rehabil 19:399–403.

    OpenUrlCrossRefPubMed
18. ↵
    1. Köck R,
    2. Becker K,
    3. Cookson B,
    4. van Gemert-Pijnen J,
    5. Harbarth S,
    6. Kluytmans J,
    7. et al.

    (2010) Methicillin-resistant Staphylococcus aureus(MRSA):burden of disease and control challenges in Europe. Euro Surveill 15:19688.

    OpenUrlCrossRefPubMed
19. ↵
    1. Adam KM,
    2. Abomughaid MM

    (2018) Prevalence of Methicillin-resistant Staphylococcus Aureus in Saudi Arabia Revisited:A Meta-analysis. Open Public Health J 11:584–591.

    OpenUrl
20. ↵
    1. Aly M,
    2. Balkhy HH

    (2012) The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries. Antimicrob Resist Infect Control 1:26.

    OpenUrl
21. ↵
    1. Byrne FM,
    2. Wilcox MH

    (2011) MRSA prevention strategies and current guidelines. Injury 42( Suppl5):S3–S6.

    OpenUrlCrossRefPubMed
22. ↵
    1. Schneider-Lindner V,
    2. Delaney JA,
    3. Dial S,
    4. Dascal A,
    5. Suissa S

    (2007) Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis 13:994–1000.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    1. Moran GJ,
    2. Krishnadasan A,
    3. Gorwitz RJ,
    4. Fosheim GE,
    5. McDougal LK,
    6. Carey RB,
    7. et al.

    (2006) EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus. infections among patients in the emergency department. N Engl J Med 355:666–674.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    1. Trucksis M,
    2. Hooper DC,
    3. Wolfson JS

    (1991) Emerging resistance to fluoroquinolones in staphylococci:an alert. Ann Intern Med 114:424–426.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    1. Tacconelli E,
    2. De Angelis G,
    3. Cataldo MA,
    4. Pozzi E,
    5. Cauda R

    (2008) Does antibiotic exposure increase the risk of Methicillin-Resistant Staphylococcus aureus(MRSA) isolation?A systematic review and meta-analysis. J Antimicrob Chemother 61:26–38.

    OpenUrlCrossRefPubMedWeb of Science